1.00

2.91% -0.03

After Hours: 1.01 0.01 +1.00%

InspireMD Inc. (NSPR)

Overview News Price History Option Chain Discussions Forecast Stock Split

InspireMD Inc. stock is traded at $1.00, with a volume of 52,120. It is down -2.91% in the last 24 hours and down -24.24% over the past month. InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.

Previous Close:

$1.03

Open:

$1.03

24h Volume:

52,120

Relative Volume:

0.23

Market Cap:

$46.84M

Revenue:

$10.85M

Net Income/Loss:

$-51.31M

P/E Ratio:

-1.3569

EPS:

-0.737

Net Cash Flow:

$-36.77M

1W Performance:

-4.76%

1M Performance:

-24.24%

6M Performance:

-48.19%

1Y Performance:

-56.14%

1-Day Range:

$1.00

$1.05

1-Week Range:

$0.97

$1.09

52-Week Range:

$0.97

$2.9319

InspireMD Inc. Stock (NSPR) Company Profile

Name

InspireMD Inc.

Sector

Healthcare (1108)

Industry

Medical Devices (143)

Phone

972 3 6917691

Address

4 Menorat Hamaor Street, Tel Aviv

Employee

Twitter

@InspireMD

Next Earnings Date

2026-05-04

Latest SEC Filings

NSPR's Discussions on Twitter

Compare NSPR vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NSPR InspireMD Inc.	1.00	48.24M	10.85M	-51.31M	-36.77M	-0.737
ABT Abbott Laboratories	87.41	152.88B	45.13B	6.28B	7.38B	3.5895
SYK Stryker Corp	316.48	120.18B	25.27B	3.34B	4.57B	8.6334
MDT Medtronic Plc	78.60	100.34B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	57.78	84.95B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	85.78	47.91B	6.30B	1.07B	1.09B	1.8406

InspireMD Inc. Stock (NSPR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-02-26	Initiated	Maxim Group	Buy
Jan-07-16	Initiated	Rodman & Renshaw	Buy
Mar-13-15	Downgrade	Oppenheimer	Outperform → Perform
Nov-26-13	Initiated	Oppenheimer	Outperform

InspireMD Inc. Stock (NSPR) Latest News

May 23, 2026

InspireMD (NSPR) Q1 2026 Earnings: EPS Beat Despite Net Loss, Shares Dip 2.9%Post-Announcement Reaction - Newser

May 23, 2026

May 22, 2026

Paul Stuka to Retire from InspireMD Board, Will Not Seek Re‑election - TradingView

May 22, 2026

InspireMD (NSPR) chair Paul Stuka plans Board retirement in 2027 - Stock Titan

May 22, 2026

NSPR Technical Analysis | Trend, Signals & Chart Patterns | INSPIREMD INC (NASDAQ:NSPR) - ChartMill

May 22, 2026

NSPR Q1 2026 Earnings: Loss Narrower Than Expected as InspireMD Advances Commercial PipelineProfit Growth Outlook - Newser

May 22, 2026

May 21, 2026

InspireMD CCO Shane Gleason sells $189,594 in stock By Investing.com - Investing.com Australia

May 21, 2026

InspireMD CCO Shane Gleason sells $189,594 in stock - Investing.com

May 21, 2026

InspireMD (NSPR) CCO auto-sells shares to cover RSU tax obligations - Stock Titan

May 21, 2026

May 17, 2026

InspireMD (NSPR) price target decreased by 13.33% to 4.42 - MSN

May 17, 2026

May 15, 2026

Nantahala reports 4.82M shares in InspireMD (NSPR) including convertibles - Stock Titan

May 15, 2026

Director Stuka increases InspireMD (NSPR) stake with 15,000-share buys - Stock Titan

May 15, 2026

Velan Capital holds 4.99% of InspireMD (NASDAQ: NSPR) via 2.35M shares - Stock Titan

May 15, 2026

NSPR Stock Price, Quote & Chart | INSPIREMD INC (NASDAQ:NSPR) - ChartMill

May 15, 2026

May 14, 2026

InspireMD CEO Marvin Slosman buys $25,200 in company stock By Investing.com - Investing.com Australia

May 14, 2026

May 13, 2026